Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. (Record no. 12640395)

MARC details
000 -LEADER
fixed length control field 01461 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514073402.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200403s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1567-5769
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1567-5769(03)00012-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Rasi, G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040329
245 00 - TITLE STATEMENT
Title Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International immunopharmacology
Date of publication, distribution, etc. Aug 2003
300 ## - PHYSICAL DESCRIPTION
Extent 1169-76 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adjuvants, Immunologic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Hepatocellular
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis B, Chronic
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis, Viral, Human
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Neoplasms
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymalfasin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymosin
General subdivision analogs & derivatives
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pierimarchi, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sinibaldi Vallebona, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Colella, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garaci, E
773 0# - HOST ITEM ENTRY
Title International immunopharmacology
Related parts vol. 3
-- no. 8
-- p. 1169-76
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1567-5769(03)00012-2">https://doi.org/10.1016/S1567-5769(03)00012-2</a>
Public note Available from publisher's website

No items available.